OpenAlex
PricingAboutJobs
Log inGet started
Work

Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011

HTML

Year: 2014
Type: article
Study design: Observational Study
Source: Blood
DOI: 10.1182/blood-2014-07-580498
Authors: Peter W. Collins, Benedict P. Palmer, Elizabeth A. Chalmers, Daniel P. Hart, Ri Liesner, Savita Rangarajan, Katherine Talks, Michael Williams, Charles R. M. Hay
Institutions: University Hospital of Wales, Royal Hospital for Children, Queen Mary University of London, Royal London Hospital, National Health Service, Great Ormond Street Hospital, Great Ormond Street Hospital for Children NHS Foundation Trust, St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, Hampshire Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Birmingham Children's Hospital, Manchester Royal Infirmary, University of Manchester
Language: English

Topic: Hemophilia Treatment and Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: factor VIII inhibitors, recombinant factor VIII, hemophilia A, Advate, immunogenicity, high-titer inhibitors, brand comparison
SDG: Good health and well-being

Open Access status: green

Funders: Pfizer, CSL Behring, Novo Nordisk
OpenAlex ID: W1997223335
FWCI: 11.39
Cites: 18
Cited by: 126
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security